SHORT MINI FUTURE WARRANT - MERCK & CO. | Real-time BOERSE MUENCHEN 15:27:25 23/05/2024 BST | ||
| 0.88 EUR | -3.30% |
|
| Current month | -18.02% | ||
| 1 month | -30.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 0.88 | -3.30% |
| 22/05/24 | 0.91 | -6.19% |
| 21/05/24 | 0.97 | +10.23% |
| 20/05/24 | 0.88 | -5.38% |
| 17/05/24 | 0.93 | +1.09% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 03:27 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GP3Z9F |
| ISIN | DE000GP3Z9F7 |
| Date issued | 04/05/2023 |
| Strike | 141 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.01 € |
|---|---|
| Lowest since issue | 0.77 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.1
USD
Average target price
141.6
USD
Spread / Average Target
+8.04%
- Stock Market
- Certificates
- Certificat
